Expanded Access Program for Epcoritamab

NCT05733650 · clinicaltrials.gov ↗

APPROVED_FOR_MARKETING

Status

INDUSTRY

Sponsor class

Conditions

Large B-cell Lymphoma
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Primary Mediastinal Large B-cell Lymphoma (PMBCL)
High Grade B-cell Lymphoma (HGBCL)
Grade 3B Follicular Lymphoma

Interventions

BIOLOGICAL: Epcoritamab

Sponsor

Genmab

Collaborators

[object Object]